CCM
MTEM

Consonance Capital Management’s Molecular Templates, Inc. MTEM Stock Holding History

Consonance Capital Management’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-115,734
Closed -$19M – 46
2020
Q3 		$19M Buy
+115,734
New +$20.6M 2.31% 17

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Consonance Capital Management's MTEM Position: Q4 2020 in Review

Consonance Capital Management sold out of Molecular Templates, Inc. (MTEM) in Q4 2020, closing a stake of 115,734 shares — an estimated $19M sold.

Consonance Capital Management first reported a position in MTEM in Q3 2020 and held it in 1 quarter. The position peaked at $19M in Q3 2020. 97 funds tracked by Wall St. Rank hold MTEM as of Q4 2020.

  • Consonance Capital Management reported no remaining Molecular Templates, Inc. position as of Q4 2020 after selling out during the quarter.
  • Consonance Capital Management sold 115,734 Molecular Templates, Inc. shares in Q4 2020, an estimated $19M.
  • Consonance Capital Management first reported a position in Molecular Templates, Inc. in Q3 2020 and held it in 1 quarter.
  • Consonance Capital Management's Molecular Templates, Inc. position peaked at $19M in Q3 2020.
  • 97 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2020.

Based on Consonance Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.